Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia

Blood

Volumn 92, Issue 7, 1998, Pages 2484-2494

  Kim, Doo Ho ^a   Lerner, Adam ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; ROLIPRAM; THEOPHYLLINE; VINPOCETINE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER THERAPY; CELL STIMULATION; CHRONIC LYMPHATIC LEUKEMIA; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0003226768     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2484     Document Type: Article

References (32)

1. Mentz F, Merle-Beral H, Ouaaz F, Binet J-L: Theophylline, a new inducer of apoptosis in B-CLL: Role of cylic nucleotides. Br J Haematol 90:957, 1995
2. Mentz F, Mossalayi MD, Ouaaz F, Baudet S, Issaly F, Ktorza S, Semichon M, Binet J-L, Merle-Beral H: Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood 88:2172, 1996
3. Binet J-L, Mentz F, Leblond V, Merle-Beral H: Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia. Leukemia 9:2159, 1995
4. Daniel V, Litwack G, Tompkins GM: Induction of cytolysis of cultured lymphoma cells by adenosine 3′:5′-cyclic monophosphate and isolation of resistant variants. Proc Natl Acad Sci USA 70:76, 1973
5. Coffino P, Bourne HR, Tomkins GM: Mechanism of lymphoma cell death induced by cyclic AMP. Am J Pathol 81:199, 1975
6. McConkey DJ, Orrenius S, Jondal M; Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol 145:1227, 1990
7. Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB: TGF-β l and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 154:1634, 1995
8. Manganiello VC, Murata T, Taira M, Belfrage P, Degerman E: Diversity in cyclic nucleotide phosphodiesterase isozyme families. Arch Biochem Biophys 322:1, 1995
9. Hurwitz RL, Hirsch KM, Clark DJ, Holcombe VN, Hurwitz MY: Induction of a calcium/calmodulin-dependent phosphodiesterase during PHA-stimulated lymphocyte mitogenesis. J Biol Chem 265:8901, 1990
10. Jiang X, Li J, Paskind M, Epstein PM: Inhibition of calmodulin dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 93: 11236, 1996
11. Hagiwara M, Endo T. Hidaka H: Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochem Pharmacol 33:453, 1984
12. Robicsek SA, Blanchard DK, Djeu JY, Krzanowski JJ, Szentivanyi A, Polson JB: Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem Pharmacol 42:869, 1991
13. Meskini N, Hosni M, Nemoz G, Lagarde M, Prigent A-F: Early increases in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells. J Cell Physiol 150:140, 1992
14. Schwabe U, Mikake M, Y O, Daly JW: 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): A potent inhibitor of adenosine cyclic 3′,5′-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Mol Pharmacol 12:900, 1976
15. Sheppard H, Wiggan G, Tsien WH: Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues. Adv Cyclic Nucl Res 1:103, 1972
16. Iannone MA, Wolberg G, Zimmerman TP: Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J Biol Chem 264:20177, 1989
17. Lobbert RW, Winterpacht A, Seipel B, Zabel BU: Molecular cloning and chromosomal assignment of the human homologue of the rat cGMP-inhibited phosphodiesterase 1 (PDE3A)-A gene involved in fat metabolism located at 11p15.1. Genomics 37:211, 1996
18. Miki T, Taira M, Hockman S, Shimada F, Lieman J, Napolitano M, Ward D, Taira M, Makino H, Manganiello V: Characterization of the cDNA and gene encoding human PDE3B, the cGIPl isoform of the human GMP-inhibited cyclic nucleotide phosphodiesterase family. Genomics 36:476, 1996
19. Meacci E, Taira M, Moos M, Smith CJ, Movsesian MA, Degerman E, Belfrage P, Manganiello V: Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc Natl Acad Sci USA 89:3721, 1992
20. Livi GP, Kmetz P, McHale MM, Cieslinski LB, Sathe GM, Taylor DP, Davis RL, Torphy TJ, Balcarek JM: Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase. Mol Cell Biol 10:2678, 1990
21. Bolger G, Michaeli T, Martins T, St. John T, Steiner B, Rodgers L, Riggs M, Wigler M, Ferguson K: A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol Cell Biol 13:6558, 1993
22. Thompson WJ, Appleman MM: Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10:311, 1971
23. Hardin JA, Sherr DH, DeMaria M, Lopez PA: A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation. J Immunol Methods 154:99, 1992
24. Thompson AA, Talley JA, Do HN, Kagan HL, Kunkel L, Berenson J, Cooper MD, Saxon A, Wall R: Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 90:1387, 1997
25. Catovsky D: The search for genetic clues in chronic lymphocytic leukemia. Hematol Cell Ther 39:S5, 1997
26. Muller T, Engels P, Fozard JR: Subtypes of the type 4 cAMP phosphodiesterases: Structure, regulation and selective inhibition. Trends Pharmacol Sci 17:294, 1996
27. Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttman MA, Hay DWP, Torphy TJ: Comparison of phosphodiesterase 3, 4 and dual 3/4 inhibition on bronchospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther 270:250, 1994
28. Banner KH, Page CP: Acute vs chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br J Pharmacol 114:93, 1995
29. Duplantier AJ. Biggers MS, Chambers RJ, Cheng JB, Cooper K, Damon DB, Eggler JF, Kraus KG, Marfat A, Masamune H, Pillar JS, Shirley JT, Umland JP, Watson JW: Biarylcarboxylic acids and -amides: Inhibition of phosphodiesterase type 4 versus [3H]Rolipram binding activity and their relationship to emetic behavior in the ferret. J Med Chem 39:120, 1996
30. Kiefer J, Okret S, Jondal M, McConkey DJ : Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line. J Immunol 155:4525, 1995
31. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: bcl-2 hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
32. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, Keating M: Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol 156:2624, 1996